国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2012年
18期
1399-1401
,共3页
王雅敏%李峤珂%胡建英%方芳
王雅敏%李嶠珂%鬍建英%方芳
왕아민%리교가%호건영%방방
无创正压通气%纳络酮%慢性阻塞性肺疾病%肺性脑病
無創正壓通氣%納絡酮%慢性阻塞性肺疾病%肺性腦病
무창정압통기%납락동%만성조새성폐질병%폐성뇌병
Non-invasive positive pressure ventilation%Allylnoroxymorphone%Chronic obstructive pulmonary disease%Pulmonary encephalopathy
目的 观察无创正压通气联合纳络酮治疗慢性阻塞性肺疾病( chronic obstructive pulmonary disease,COPD)合并肺性脑病的临床疗效.方法 将86例COPD合并肺性脑病患者随机分为两组,对照组和治疗组,各43例.在常规治疗基础上,对照组给予无创正压通气治疗,治疗组使用无创正压通气联合纳洛酮治疗.结果 治疗组在治疗后2h、48 h PCO2较治疗前明显改善(P<0.01),治疗后2h、48 h pH、PCO2优于对照组(P<0.05或P<0.01).治疗组气管插管率23%,对照组为42%.结论 使用无创正压通气联合纳洛酮治疗COPD肺性脑病患者,较单纯无创正压通气可以更早更有效地改善二氧化碳潴留和pH值,缩短神志恢复时间,降低气管插管率.
目的 觀察無創正壓通氣聯閤納絡酮治療慢性阻塞性肺疾病( chronic obstructive pulmonary disease,COPD)閤併肺性腦病的臨床療效.方法 將86例COPD閤併肺性腦病患者隨機分為兩組,對照組和治療組,各43例.在常規治療基礎上,對照組給予無創正壓通氣治療,治療組使用無創正壓通氣聯閤納洛酮治療.結果 治療組在治療後2h、48 h PCO2較治療前明顯改善(P<0.01),治療後2h、48 h pH、PCO2優于對照組(P<0.05或P<0.01).治療組氣管插管率23%,對照組為42%.結論 使用無創正壓通氣聯閤納洛酮治療COPD肺性腦病患者,較單純無創正壓通氣可以更早更有效地改善二氧化碳潴留和pH值,縮短神誌恢複時間,降低氣管插管率.
목적 관찰무창정압통기연합납락동치료만성조새성폐질병( chronic obstructive pulmonary disease,COPD)합병폐성뇌병적림상료효.방법 장86례COPD합병폐성뇌병환자수궤분위량조,대조조화치료조,각43례.재상규치료기출상,대조조급여무창정압통기치료,치료조사용무창정압통기연합납락동치료.결과 치료조재치료후2h、48 h PCO2교치료전명현개선(P<0.01),치료후2h、48 h pH、PCO2우우대조조(P<0.05혹P<0.01).치료조기관삽관솔23%,대조조위42%.결론 사용무창정압통기연합납락동치료COPD폐성뇌병환자,교단순무창정압통기가이경조경유효지개선이양화탄저류화pH치,축단신지회복시간,강저기관삽관솔.
Objective To observe the effect of non -invasive positive pressure ventilation (NIPPV) combined with allylnoroxymorphone on chronic obstructive pulmonary disease (COPD) with pulmonary encephalopathy.Methods 86 cases of COPD patients combined with pulmonary encephalopathy were randomly divided into 2 groups,treatment group and controi group. On the basis of routine treatment,the control group was treated with NIPPV,while the treatment group was treated with NIPPV combined with allylnoroxymorphone.Results The levels PCO2 was significantly improved at 2 and 48 hours in treatment group compared to those at baseline ( P <0.01).The level of PCO2 and pH at 2 and 48 hours in treatment group was significantly superior to those in control group ( P <0.05 or P <0.01).The tracheal intubation rate of the treatment group was 23%,while that of the control group was 42%.Conclusions Compared with NIPPV treatment alone on COPD patients with pulmonary encephalopathy,combined NIPPV and allylnoroxymorphone treatment can improve carbon dioxide retention and the level of pH more earlier and effective,and can shorten the time of consciousness recovered,decrease the tracheal intubation rate.